Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

C Todd Brady


  • President And Ceo at Aldeyra Therapeutics Inc. (ALDX), 2019-10-02
  • Director at Spring Bank Pharmaceuticals Inc. (SBPH), 2019-10-01
  • Director at Evoke Pharma Inc (EVOK), 2019-05-03
  • Director at Oncobiologics Inc. (ONS), 2017-10-30
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALDX $5.68 8,710 Officer, Director 632,216 2019-09-30 Filing
ALDX $5.81 8,680 Officer, Director 623,506 2019-09-23 Filing
ALDX $5.91 14,288 Officer, Director 614,826 2019-09-18 Filing
ALDX $6.03 3,000 Officer, Director 600,538 2019-09-16 Filing
ALDX $5.90 18,547 Officer, Director 597,538 2019-09-13 Filing